OUR SERVICES INCLUDE BUT NOT LIMITED TO

• Biosimilars and biobetters licensing

• Market Entry Strategy

• Product In-licensing/Out-licensing

• Product Portfolio Selection

• Product Partnering Strategy

• Diagnostic Development and Commercialization

Business development, product partnering, M&As, penetrating to markets and licensing pharmaceuticals are also among the services offered, as well as advice on feasibility studies, manufacturing, drug development, formulation, and pipeline analysis.

The Riverside Research Information also conducts research on the latest industry trends and therapeutic classes. Having worked with businesses of all sizes all over the world, the coverage includes the United States, Canada, the European Union, Japan, India, China, Middle East and the rest of the world. RRI has extensive relationships at the senior executive levels and networks with expert opinions and insights on the global biotech and pharmaceutical landscape, allowing for more efficient and informed decision-making.

RRI’s extensive global experience, robust network, and expertise in biopharma science and business makes us a trusted partner for the world’s leading pharma and biotech companies. RRI is always looking for new ways to assist its clients in their mission to revolutionize healthcare and increase their return of investment.

Proudly worked previously with